British biotech startup ImmunONE raises £2M for 3D human lung model to replace animal testing

ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. Here are details of ImmuONE‘s latest funding round :

🚀 Launch

2019

🏭 Industry

Biotechnology

🧠Management

DR ABIGAIL MARTIN (CEO CO-FOUNDER), DR VICTORIA HUTTER (CSO CO-FOUNDER), DR EWELINA HOFFMAN (PRINCIPAL LEAD SCIENTIST)

💸 Funding & Investors

INVESTMENT (October 2023)£2 million
INVESTORS (October 2023)led by MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia Ventures and part of the Midlands Engine Investment Fund (MEIF).

🎯 Funding purpose

Move into new headquarters in Milton Keynes, new laboratories in Stevenage to meet the growing demand and additionally expand capacity, continue its research and development, grow its team and create six new jobs. 

🌐 Country HQ

UK (Hatfield)

Leave a Reply

Your email address will not be published.